Page 233 - ILAE_Lectures_2015

149. BOUILLERET V, DUPONT S, SPELLE L et al (2002) Insular cortex involvement in mesiotemporal lobe epilepsy:

a positron emission tomography study. Ann Neurol 51(2), 202208.
150. LAMUSUO S, JUTILA L, YLINEN A et al (2001) [18F]FDG-PET reveals temporal hypometabolism in patients

with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild

hippocampal damage. Arch Neurol 58(6), 933939.
151. KNOWLTON RC, LAXER KD, KLEIN G et al (2001) In vivo hippocampal glucose metabolism in mesial temporal

lobe epilepsy. Neurology 57(7), 11841190.
152. GAILLARD WD, KOPYLEV L, WEINSTEIN S et al (2002) Low incidence of abnormal (18)FDG-PET in children

with new-onset partial epilepsy: a prospective study. Neurology 58(5), 717722.
153. ENGEL J, HENRY TR, SWARTZ BE (1995) Positron Emission Tomography in Frontal Lobe Epilepsy. Epilepsy

and the Functional Anatomy of the Frontal Lobe, Eds Jasper HH, Riggio S, Goldman-Rakic PS), pp. 223238.
Raven Press, New York.
154. DE VOLDER AG, GADISSEUX JF, MICHEL CJ et al (1994) Brain glucose utilization in band heterotopia:

synaptic activity of ‘double cortex’. Pediatr Neurol 11, 290294.
155. BAIRAMIAN D, DI CHIRO G, THEODORE WH et al (1985) MR imaging and positron emission tomography of

cortical heterotopia. Comp Assis Tomogr 9, 11371139.
156. FALCONER J, WADA JA, MARTIN W, LI D (1990) PET, CT, and MRI imaging of neuronal migration anomalies

in epileptic patients. Can J Neurol Sci 17, 3539.
157. RICHARDSON MP, KOEPP MJ, BROOKS DJ et al (1998) Cerebral activation in malformations of cortical

development. Brain 121, 12951304.
158. MULLER RA, BEHEN ME, MUZIK O et al (1998) Task-related activations in heterotopic brain malformations: a

PET study. Neuroreport 9, 25272533.
159. SZELIES B, WEBER-LUXENBURGER G, PAWLIK G et al (1996) MRI-guided flumazenil- and FDG-PET in

temporal lobe epilepsy. Neuroimage 3, 109118.
160. DEBETS RM, SADZOT B, VAN ISSELT JW et al (1997) Is 11C-flumazenil PET superior to 18FDG PET and

123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry 62,

141150.
161. JUHASZ C, CHUGANI DC, MUZIK O et al (2000) Electroclinical correlates of flumazenil and

fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology 55, 825835.
162. KOEPP MJ, RICHARDSON MP, BROOKS DJ et al (1996) Central benzodiazepine receptors in hippocampal

sclerosis: an objective in vivo analysis. Brain 119, 16771687.
163. KOEPP MJ, RICHARDSON MP, LABBE C et al (1997) 11C-flumazenil PET, volumetric MRI and quantitative

pathology in mesial temporal lobe epilepsy. Neurology 49, 764773.
164. KOEPP MJ, LABBE C, RICHARDSON MP et al (1997) Regional hippocampal [11C]-flumazenil PET in temporal

lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 120, 18651876.
165. HAMMERS A, KOEPP MJ, LABBE C et al (2001) Neocortical abnormalities of [11C]-flumazenil PET in mesial

temporal lobe epilepsy. Neurology 56(7), 897906.
166. HAND KSP, BAIRD VH, VAN PAESSCHEN W et al (1997) Central benzodiazepine receptor autoradiography in

hippocampal sclerosis. Br J Pharmacol 122, 358364.
167. KOEPP MJ, HAND KSP, LABBE C et al (1998). In vivo 11C-flumazenil PET correlates with ex vivo 3H-

flumazenil autoradiography in hippocampal sclerosis. Ann Neurol 43, 618626.
168. RYVLIN P, BOUVARD S, LE BARS D et al (1998) Clinical utility of flumazenil-PET versus FDG-PET and MRI

in refractory partial epilepsy. A prospective study in 100 patients. Brain 121, 20672081.
169. MAYBERG HS, SADZOT B, MELTZER CC et al (1991) Quantification of mu and non-mu opiate receptors in

temporal lobe epilepsy using positron emission tomography. Ann Neurol 30, 311.
170. KOEPP MJ, RICHARDSON MP, BROOKS DJ, DUNCAN JS (1998) Focal cortical release of endogenous opioids

during reading induced seizures. Lancet 352, 952955.
171. KUMLIEN E, NILSSON A, HAGBERG G et al (2001) PET with 11C-deuterium-deprenyl and 18F-FDG in focal

epilepsy. Acta Neurol Scand 103(6), 360366.
171. CHUGANI DC, CHUGANI HT, MUZIK O et al (1998) Imaging epileptogenic tubers in children with tuberous

sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 44, 858866.
173. WAKAMOTO H, CHUGANI DC, JUHASZ C et al (2008) Alpha-Methyl-l-Tryptophan positron emission

tomography in epilepsy with cortical developmental malformations. Pediatr Neurol 39, 181188.
174. FEDI M, REUTENS D, OKAZAWA H et al (2001) Localizing value of alpha-methyl-L-tryptophan PET in

intractable epilepsy of neocortical origin. Neurology 57(9), 16291636.
175. JUHASZ C, CHUGANI DC, MUZIK O et al (2003) Alpha-methyl-L-tryptophan PET detects epileptogenic cortex

in children with intractable epilepsy. Neurology 60(6), 960968.
176. NATSUME J, KUMAKURA Y, BERNASCONI N et al (2003) Alpha-[11C] methyl-L-tryptophan and glucose

metabolism in patients with temporal lobe epilepsy. Neurology 60(5), 756761.
177. KNOWLTON RC, EGLAVISH RA, LIMDI N et al (2008) Functional imaging: I. Relative predictive value of

intracranial electroencephalography. Ann Neurol 64, 2534.
178. KNOWLTON RC, EGLAVISH RA, BARTOLUCCI A et al (2008) Functional imaging: II. Prediction of epilepsy

surgery outcome. Ann Neurol 64, 3541.
179. AKHONDI-ASL A, JAFARI-KHOUZANI K, ELISEVICH K, SOLTANIAN-ZADEH H (2011) Hippocampal

volumetry for lateralization of temporal lobe epilepsy: automated versus manual methods. Neuroimage 54 (Suppl
1), S218–226.